Gilead Sciences completes $7.8 billion Arcellx acquisition
Go back to Gilead Sciences completes $7.8 billion Arcellx acquisition| (NASDAQ: ACLX) | Delayed: 115.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $115.07 | 52 Week High | $ | |||
| Open | $115.07 | 52 Week Low | $ | |||
| Day High | $115.07 | P/E | N/A | |||
| Day Low | $115.07 | EPS | $ | |||
| Volume | 622 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 129.31 -1.55 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $130.86 | 52 Week High | $108.63 | |||
| Open | $130.93 | 52 Week Low | $71.39 | |||
| Day High | $131.65 | P/E | 71.44 | |||
| Day Low | $129.04 | EPS | $1.81 | |||
| Volume | 5,529,733 | |||||
